Epigenetics and Trained Immunity

Antioxidants and Redox Signaling

Volumn 29, Issue 11, 2018, Pages 1023-1040

  Van Der Heijden, Charlotte D C C ^a   Noz, Marlies P ^a   Joosten, Leo A B ^a   Netea, Mihai G ^a,b   Riksen, Niels P ^a   Keating, Samuel T ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

epigenetics; innate immunity; macrophage; memory; monocyte; trained immunity

Indexed keywords

DNA; HISTONE; LYSINE;

CELL DIFFERENTIATION; CELL METABOLISM; CHROMATIN; CHROMATIN STRUCTURE; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION REGULATION; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION; ANIMAL; ATHEROSCLEROSIS; GENETIC EPIGENESIS; GENETICS; IMMUNOLOGY; MONOCYTE;

ANIMALS; ATHEROSCLEROSIS; EPIGENESIS, GENETIC; HUMANS; IMMUNITY, INNATE; MACROPHAGES; MONOCYTES; PHENOTYPE;

EID: 85052989404     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2017.7310     Document Type: Review

References (154)

1. Aaby P, Roth A, Ravn H, Napirna BM, Rodrigues A, Lisse IM, Stensballe L, Diness BR, Lausch KR, Lund N, Biering-Sorensen S, Whittle H, and Benn CS. Randomized trial of BCG vaccination at birth to low-birthweight children: beneficial nonspecific effects in the neonatal period? J Infect Dis 204: 245-252, 2011.
2. Alvarez-Errico D, Vento-Tormo R, Sieweke M, and Ballestar E. Epigenetic control of myeloid cell differentiation, identity and function. Nat Rev Immunol 15: 7-17, 2015.
3. Aronson JD. Protective vaccination against tuberculosis, with special reference to BCG vaccine. Minn Med 31: 1336, 1948.
4. Arts RJ, Carvalho A, La Rocca C, Palma C, Rodrigues F, Silvestre R, Kleinnijenhuis J, Lachmandas E, Goncalves LG, Belinha A, Cunha C, Oosting M, Joosten LA, Matarese G, van Crevel R, and Netea MG. Immunometabolic pathways in BCG-induced trained immunity. Cell Rep 17: 2562-2571, 2016.
5. Arts RJ, Novakovic B, Ter Horst R, Carvalho A, Bekkering S, Lachmandas E, Rodrigues F, Silvestre R, Cheng SC, Wang SY, Habibi E, Goncalves LG, Mesquita I, Cunha C, van Laarhoven A, van de Veerdonk FL, Williams DL, van der Meer JW, Logie C, O'Neill LA, Dinarello CA, Riksen NP, van Crevel R, Clish C, Notebaart RA, Joosten LA, Stunnenberg HG, Xavier RJ, and Netea MG. Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity. Cell Metab 24: 807-819, 2016.
6. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, and Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837, 2007.
7. Becker PB and Workman JL. Nucleosome remodeling and epigenetics. Cold Spring Harb Perspect Biol 5: 1-20, 2013.
8. Bekkering S, Blok BA, Joosten LA, Riksen NP, van Crevel R, and Netea MG. In vitro experimental model of trained innate immunity in human primary monocytes. Clin Vaccine Immunol 23: 926-933, 2016.
9. Bekkering S, Quintin J, Joosten LA, van der Meer JW, Netea MG, and Riksen NP. Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes. Arterioscler Thromb Vasc Biol 34: 1731-1738, 2014.
10. Bekkering S, van den Munckhof I, Nielen T, Lamfers E, Dinarello C, Rutten J, de Graaf J, Joosten LA, Netea MG, Gomes ME, and Riksen NP. Innate immune cell activation and epigenetic remodeling in symptomatic and asymptomatic atherosclerosis in humans in vivo. Atherosclerosis 254: 228-236, 2016.
11. Bernstein BE, Kamal M, Lindblad-Toh K, Bekiranov S, Bailey DK, Huebert DJ, McMahon S, Karlsson EK, Kulbokas EJ, 3rd, Gingeras TR, Schreiber SL, and Lander ES. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120: 169-181, 2005.
12. Beyer S, Kristensen MM, Jensen KS, Johansen JV, and Staller P. The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. J Biol Chem 283: 36542-36552, 2008.
13. Biering-Sorensen S, Aaby P, Napirna BM, Roth A, Ravn H, Rodrigues A, Whittle H, and Benn CS. Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guerin vaccination at first health center contact. Pediatr Infect Dis J 31: 306-308, 2012.
14. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21, 2002.
15. Bistoni F, Vecchiarelli A, Cenci E, Puccetti P, Marconi P, and Cassone A. Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infect Immun 51: 668-674, 1986.
16. Borriello F, Iannone R, Di Somma S, Loffredo S, Scamardella E, Galdiero MR, Varricchi G, Granata F, Portella G, and Marone G. GM-CSF and IL-3 modulate human monocyte TNF-alpha production and renewal in in vitro models of trained immunity. Front Immunol 7: 680, 2016.
17. Brasacchio D, Okabe J, Tikellis C, Balcerczyk A, George P, Baker EK, Calkin AC, Brownlee M, Cooper ME, and El-Osta A. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 58: 1229-1236, 2009.
18. Breiling A and Lyko F. Epigenetic regulatory functions of DNA modifications: 5-methylcytosine and beyond. Epigenetics Chromatin 8: 24, 2015.
19. Buffen K, Oosting M, Quintin J, Ng A, Kleinnijenhuis J, Kumar V, van de Vosse E, Wijmenga C, van Crevel R, Oosterwijk E, Grotenhuis AJ, Vermeulen SH, Kiemeney LA, van de Veerdonk FL, Chamilos G, Xavier RJ, van der Meer JW, Netea MG, and Joosten LA. Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer. PLoS Pathog 10: e1004485, 2014.
20. C. N. Experiences with the BCG vaccination in the providence of Norbotten (Sweden). Revue de la Tuberculose 12: 617-636, 1931.
21. Calo E and Wysocka J. Modification of enhancer chromatin: what, how, and why? Mol Cell 49: 825-837, 2013.
22. Carr SM, Poppy Roworth A, Chan C, and La Thangue NB. Post-translational control of transcription factors: methylation ranks highly. FEBS J 282: 4450-4465, 2015.
23. Chen Z, Miao F, Paterson AD, Lachin JM, Zhang L, Schones DE, Wu X, Wang J, Tompkins JD, Genuth S, Braffett BH, Riggs AD, Group DER, and Natarajan R. Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort. Proc Natl Acad Sci U S A 113: E3002-E3011, 2016.
24. Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, Giamarellos-Bourboulis EJ, Martens JH, Rao NA, Aghajanirefah A, Manjeri GR, Li Y, Ifrim DC, Arts RJ, van der Veer BM, Deen PM, Logie C, O'Neill LA, Willems P, van de Veerdonk FL, van der Meer JW, Ng A, Joosten LA, Wijmenga C, Stunnenberg HG, Xavier RJ, and Netea MG. mTOR-and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345: 1250684, 2014.
25. Chistiakov DA, Bobryshev YV, Nikiforov NG, Elizova NV, Sobenin IA, and Orekhov AN. Macrophage phenotypic plasticity in atherosclerosis: the associated features and the peculiarities of the expression of inflammatory genes. Int J Cardiol 184: 436-445, 2015.
26. Choi I, Kim R, Lim HW, Kaestner KH, and Won KJ. 5-Hydroxymethylcytosine represses the activity of enhancers in embryonic stem cells: a new epigenetic signature for gene regulation. BMC Genomics 15: 670, 2014.
27. Christ A, Bekkering S, Latz E, and Riksen NP. Long-term activation of the innate immune system in atherosclerosis. Semin Immunol 28: 384-393, 2016.
28. Colin S, Chinetti-Gbaguidi G, and Staels B. Macrophage phenotypes in atherosclerosis. Immunol Rev 262: 153-166, 2014.
29. Cooper ME and El-Osta A. Epigenetics: mechanisms and implications for diabetic complications. Circ Res 107: 1403-1413, 2010.
30. Crisan TO, Cleophas MCP, Novakovic B, Erler K, van de Veerdonk FL, Stunnenberg HG, Netea MG, Dinarello CA, and Joosten LAB. Uric acid priming in human monocytes is driven by the AKT-PRAS40 autophagy pathway. Proc Natl Acad Sci U S A 114: 5485-5490, 2017.
31. Dasgupta M, Dermawan JK, Willard B, and Stark GR. STAT3-driven transcription depends upon the dimethylation of K49 by EZH2. Proc Natl Acad Sci U S A 112: 3985-3990, 2015.
32. Donohoe DR and Bultman SJ. Metaboloepigenetics: interrelationships between energy metabolism and epigenetic control of gene expression. J Cell Physiol 227: 3169-3177, 2012.
33. Durrant WE and Dong X. Systemic acquired resistance. Annu Rev Phytopathol 42: 185-209, 2004.
34. Ea CK and Baltimore D. Regulation of NF-kappaB activity through lysine monomethylation of p65. Proc Natl Acad Sci U S A 106: 18972-18977, 2009.
35. Eberharter A and Becker PB. Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep 3: 224-229, 2002.
36. El Gazzar M, Liu T, Yoza BK, and McCall CE. Dynamic and selective nucleosome repositioning during endotoxin tolerance. J Biol Chem 285: 1259-1271, 2010.
37. Farlik M, Halbritter F, Muller F, Choudry FA, Ebert P, Klughammer J, Farrow S, Santoro A, Ciaurro V, Mathur A, Uppal R, Stunnenberg HG, Ouwehand WH, Laurenti E, Lengauer T, Frontini M, and Bock C. DNA methylation dynamics of human hematopoietic stem cell differentiation. Cell Stem Cell 19: 808-822, 2016.
38. Ferguson RG and Simes AB. BCG vaccination of Indian infants in Saskatchewan. Tubercle 30: 5-11, 1949.
39. Finch JT, Lutter LC, Rhodes D, Brown RS, Rushton B, Levitt M, and Klug A. Structure of nucleosome core particles of chromatin. Nature 269: 29-36, 1977.
40. Foster SL, Hargreaves DC, and Medzhitov R. Genespecific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972-978, 2007.
41. Fuks F, Hurd PJ, Deplus R, and Kouzarides T. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res 31: 2305-2312, 2003.
42. Gosselin D, Link VM, Romanoski CE, Fonseca GJ, Eichenfield DZ, Spann NJ, Stender JD, Chun HB, Garner H, Geissmann F, and Glass CK. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 159: 1327-1340, 2014.
43. Harikrishnan KN, Chow MZ, Baker EK, Pal S, Bassal S, Brasacchio D, Wang L, Craig JM, Jones PL, Sif S, and El-Osta A. Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat Genet 37: 254-264, 2005.
44. Hino S, Sakamoto A, Nagaoka K, Anan K, Wang Y, Mimasu S, Umehara T, Yokoyama S, Kosai K, and Nakao M. FAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure. Nat Commun 3: 758, 2012.
45. Hoeksema MA and de Winther MP. Epigenetic regulation of monocyte and macrophage function. Antioxid Redox Signal 25: 758-774, 2016.
46. Hoeksema MA, Gijbels MJ, Van den Bossche J, van der Velden S, Sijm A, Neele AE, Seijkens T, Stoger JL, Meiler S, Boshuizen MC, Dallinga-Thie GM, Levels JH, Boon L, Mullican SE, Spann NJ, Cleutjens JP, Glass CK, Lazar MA, de Vries CJ, Biessen EA, Daemen MJ, Lutgens E, and de Winther MP. Targeting macrophage histone deacetylase 3 stabilizes atherosclerotic lesions. EMBO Mol Med 6: 1124-1132, 2014.
47. Hoeksema MA, Scicluna BP, Boshuizen MC, van der Velden S, Neele AE, Van den Bossche J, Matlung HL, van den Berg TK, Goossens P, and de Winther MP. IFNgamma priming of macrophages represses a part of the inflammatory program and attenuates neutrophil recruitment. J Immunol 194: 3909-3916, 2015.
48. Hull EE, Montgomery MR, and Leyva KJ. HDAC inhibitors as epigenetic regulators of the immune system: impacts on cancer therapy and inflammatory diseases. Biomed Res Int 2016: 8797206, 2016.
49. Hyun K, Jeon J, Park K, and Kim J. Writing, erasing and reading histone lysine methylations. Exp Mol Med 49: e324, 2017.
50. Ifrim DC, Quintin J, Joosten LA, Jacobs C, Jansen T, Jacobs L, Gow NA, Williams DL, van der Meer JW, and Netea MG. Trained immunity or tolerance: opposing functional programs induced in human monocytes after engagement of various pattern recognition receptors. Clin Vaccine Immunol 21: 534-545, 2014.
51. Jenuwein T and Allis CD. Translating the histone code. Science 293: 1074-1080, 2001.
52. Jin J, Lian T, Gu C, Yu K, Gao YQ, and Su XD. The effects of cytosine methylation on general transcription factors. Sci Rep 6: 29119, 2016.
53. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 13: 484-492, 2012.
54. Jones PA and Takai D. The role of DNA methylation in mammalian epigenetics. Science 293: 1068-1070, 2001.
55. Josling GA, Selvarajah SA, Petter M, and Duffy MF. The role of bromodomain proteins in regulating gene expression. Genes (Basel) 3: 320-343, 2012.
56. Kaikkonen MU, Spann NJ, Heinz S, Romanoski CE, Allison KA, Stender JD, Chun HB, Tough DF, Prinjha RK, Benner C, and Glass CK. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol Cell 51: 310-325, 2013.
57. Keating ST and El-Osta A. Epigenetics and metabolism. Circ Res 116: 715-736, 2015.
58. Keating ST and El-Osta A. Transcriptional regulation by the Set7 lysinemethyltransferase. Epigenetics 8: 361-372, 2013.
59. Keating ST, Plutzky J, and El-Osta A. Epigenetic changes in diabetes and cardiovascular risk. Circ Res 118: 1706-1722, 2016.
60. Keating ST, Riksen NP, and Netea MG. Planarians SET new paths for innate immune memory. EBioMedicine 20: 7-8, 2017.
61. Keating ST, Ziemann M, Okabe J, Khan AW, Balcerczyk A, and El-Osta A. Deep sequencing reveals novel Set7 networks. Cell Mol Life Sci 71: 4471-4486, 2014.
62. Khan AW, Ziemann M, Corcoran SJ, K NH, Okabe J, Rafehi H, Maxwell SS, Esler MD, and El-Osta A. NET silencing by let-7i in postural tachycardia syndrome. JCI Insight 2: e90183, 2017.
63. Kim E, Kim M, Woo DH, Shin Y, Shin J, Chang N, Oh YT, Kim H, Rheey J, Nakano I, Lee C, Joo KM, Rich JN, Nam DH, and Lee J. Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell 23: 839-852, 2013.
64. Kim Y, Nam HJ, Lee J, Park DY, Kim C, Yu YS, Kim D, Park SW, Bhin J, Hwang D, Lee H, Koh GY, and Baek SH. Methylation-dependent regulation of HIF-1alpha stability restricts retinal and tumour angiogenesis. Nat Commun 7: 10347, 2016.
65. Kittan NA, Allen RM, Dhaliwal A, Cavassani KA, Schaller M, Gallagher KA, Carson WFT, Mukherjee S, Grembecka J, Cierpicki T, Jarai G, Westwick J, Kunkel SL, and Hogaboam CM. Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes. PLoS One 8: e78045, 2013.
66. Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Ifrim DC, Saeed S, Jacobs C, van Loenhout J, de Jong D, Stunnenberg HG, Xavier RJ, van der Meer JW, van Crevel R, and Netea MG. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A 109: 17537-17542, 2012.
67. Krieg AJ, Rankin EB, Chan D, Razorenova O, Fernandez S, and Giaccia AJ. Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1 alpha enhances hypoxic gene expression and tumor growth. Mol Cell Biol 30: 344-353, 2010.
68. Lachmandas E, Boutens L, Ratter JM, Hijmans A, Hooiveld GJ, Joosten LA, Rodenburg RJ, Fransen JA, Houtkooper RH, van Crevel R, Netea MG, and Stienstra R. Microbial stimulation of different Toll-like receptor signalling pathways induces diverse metabolic programmes in human monocytes. Nat Microbiol 2: 16246, 2016.
69. Lamb DJ, Eales LJ, and Ferns GA. Immunization with bacillus Calmette-Guerin vaccine increases aortic atherosclerosis in the cholesterol-fed rabbit. Atherosclerosis 143: 105-113, 1999.
70. Lanouette S, Mongeon V, Figeys D, and Couture JF. The functional diversity of protein lysine methylation. Mol Syst Biol 10: 724, 2014.
71. Lara-Astiaso D, Weiner A, Lorenzo-Vivas E, Zaretsky I, Jaitin DA, David E, Keren-Shaul H, Mildner A, Winter D, Jung S, Friedman N, and Amit I. Immunogenetics. Chromatin state dynamics during blood formation. Science 345: 943-949, 2014.
72. Lauberth SM, Nakayama T, Wu X, Ferris AL, Tang Z, Hughes SH, and Roeder RG. H3K4me3 interactions with TAF3 regulate preinitiation complex assembly and selective gene activation. Cell 152: 1021-1036, 2013.
73. Lawrence M, Daujat S, and Schneider R. Lateral thinking: how histone modifications regulate gene expression. Trends Genet 32: 42-56, 2016.
74. Lee JY, Park JH, Choi HJ, Won HY, Joo HS, Shin DH, Park MK, Han B, Kim KP, Lee TJ, Croce CM, and Kong G. LSD1 demethylates HIF1alpha to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesis. Oncogene 36: 5512-5521, 2017.
75. Levine MI and Sackett MF. Results of BCG immunization in New York City. Am Rev Tuberc 53: 517-532, 1946.
76. LevyD, Kuo AJ, Chang Y, Schaefer U, KitsonC, Cheung P, Espejo A, Zee BM, Liu CL, Tangsombatvisit S, Tennen RI, Kuo AY, Tanjing S, Cheung R, Chua KF, Utz PJ, Shi X, Prinjha RK, LeeK, Garcia BA, BedfordMT, TarakhovskyA, Cheng X, and Gozani O. Lysine methylation of the NFkappaB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-kappaB signaling. Nat Immunol 12: 29-36, 2011.
77. Li Y, Reddy MA, Miao F, Shanmugam N, Yee JK, Hawkins D, Ren B, and Natarajan R. Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem 283: 26771-26781, 2008.
78. Liu X, Chen Z, Xu C, Leng X, Cao H, Ouyang G, and Xiao W. Repression of hypoxia-inducible factor alpha signaling by Set7-mediated methylation. Nucleic Acids Res 43: 5081-5098, 2015.
79. Locht C and Mielcarek N. Live attenuated vaccines against pertussis. Expert Rev Vaccines 13: 1147-1158, 2014.
80. Lorenzen JM and Thum T. Long noncoding RNAs in kidney and cardiovascular diseases. Nat Rev Nephrol 12: 360-373, 2016.
81. Low Wang CC, Hess CN, Hiatt WR, and Goldfine AB. Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus-mechanisms, management, and clinical considerations. Circulation 133: 2459-2502, 2016.
82. Lu C and Thompson CB. Metabolic regulation of epigenetics. Cell Metab 16: 9-17, 2012.
83. Lu C, Ward PS, Kapoor GS, Rohle D, Turcan S, Abdel-Wahab O, Edwards CR, Khanin R, Figueroa ME, Melnick A, Wellen KE, O'Rourke DM, Berger SL, Chan TA, Levine RL, Mellinghoff IK, and Thompson CB. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483: 474-478, 2012.
84. Lu T, Jackson MW, Wang B, Yang M, Chance MR, Miyagi M, Gudkov AV, and Stark GR. Regulation of NFkappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65. Proc Natl Acad Sci U S A 107: 46-51, 2010.
85. Masatsugu T and Yamamoto K. Multiple lysine methylation of PCAF by Set9 methyltransferase. Biochem Biophys Res Commun 381: 22-26, 2009.
86. Meloni M and Testa G. Scrutinizing the epigenetics revolution. Biosocieties 9: 431-456, 2014.
87. Milite C, Feoli A, Viviano M, Rescigno D, Cianciulli A, Balzano AL, Mai A, Castellano S, and Sbardella G. The emerging role of lysine methyltransferase SETD8 in human diseases. Clin Epigenetics 8: 102, 2016.
88. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, and Fallon JT. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 90: 775-778, 1994.
89. Moss JT and Kadmon D. BCG and the treatment of superficial bladder cancer. DICP 25: 1355-1367, 1991.
90. Nagy C and Haschemi A. Time and demand are two critical dimensions of immunometabolism: the process of macrophage activation and the pentose phosphate pathway. Front Immunol 6: 164, 2015.
91. Netea MG, Joosten LA, Latz E, Mills KH, Natoli G, Stunnenberg HG, O'Neill LA, and Xavier RJ. Trained immunity: a program of innate immune memory in health and disease. Science 352: aaf1098, 2016.
92. Netea MG, Quintin J, and van der Meer JW. Trained immunity: a memory for innate host defense. Cell Host Microbe 9: 355-361, 2011.
93. Netea MG and van der Meer JW. Trained immunity: an ancient way of remembering. Cell Host Microbe 21: 297-300, 2017.
94. Nguyen TH, Maltby S, Eyers F, Foster PS, and Yang M. Bromodomain and extra terminal (BET) inhibitor suppresses macrophage-driven steroid-resistant exacerbations of airway hyper-responsiveness and inflammation. PLoS One 11: e0163392, 2016.
95. Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, Chung CW, Chandwani R, Marazzi I, Wilson P, Coste H, White J, Kirilovsky J, Rice CM, Lora JM, Prinjha RK, Lee K, and Tarakhovsky A. Suppression of inflammation by a synthetic histone mimic. Nature 468: 1119-1123, 2010.
96. Norouzitallab P, Baruah K, Biswas P, Vanrompay D, and Bossier P. Probing the phenomenon of trained immunity in invertebrates during a transgenerational study, using brine shrimp Artemia as a model system. Sci Rep 6: 21166, 2016.
97. Novakovic B, Habibi E, Wang SY, Arts RJ, Davar R, Megchelenbrink W, Kim B, Kuznetsova T, Kox M, Zwaag J, Matarese F, van Heeringen SJ, Janssen-Megens EM, Sharifi N, Wang C, Keramati F, Schoonenberg V, Flicek P, Clarke L, Pickkers P, Heath S, Gut I, Netea MG, Martens JH, Logie C, and Stunnenberg HG. beta-Glucan reverses the epigenetic state of LPS-induced immunological tolerance. Cell 167: 1354-1368. e1314, 2016.
98. O'Neill LA, Kishton RJ, and Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol 16: 553-565, 2016.
99. Ostuni R, Piccolo V, Barozzi I, Polletti S, Termanini A, Bonifacio S, Curina A, Prosperini E, Ghisletti S, and Natoli G. Latent enhancers activated by stimulation in differentiated cells. Cell 152: 157-171, 2013.
100. Ovchinnikova OA, Berge N, Kang C, Urien C, Ketelhuth DF, Pottier J, Drouet L, Hansson GK, Marchal G, Back M, Schwartz-Cornil I, and Lagranderie M. Mycobacterium bovis BCG killed by extended freeze-drying induces an immunoregulatory profile and protects against atherosclerosis. J Intern Med 275: 49-58, 2014.
101. Paneni F, Costantino S, Battista R, Castello L, Capretti G, Chiandotto S, Scavone G, Villano A, Pitocco D, Lanza G, Volpe M, Luscher TF, and Cosentino F. Adverse epigenetic signatures by histone methyltransferase Set7 contribute to vascular dysfunction in patients with type 2 diabetes mellitus. Circ Cardiovasc Genet 8: 150-158, 2015.
102. Park JM, Jo SH, Kim MY, Kim TH, and Ahn YH. Role of transcription factor acetylation in the regulation of metabolic homeostasis. Protein Cell 6: 804-813, 2015.
103. Petit J and Wiegertjes GF. Long-lived effects of administering beta-glucans: indications for trained immunity in fish. Dev Comp Immunol 64: 93-102, 2016.
104. Pfister SX and Ashworth A. Marked for death: targeting epigenetic changes in cancer. Nat Rev Drug Discov 16: 241-263, 2017.
105. Pham LN, Dionne MS, Shirasu-Hiza M, and Schneider DS. A specific primed immune response in Drosophila is dependent on phagocytes. PLoS Pathog 3: e26, 2007.
106. Quintin J, Saeed S, Martens JH, Giamarellos-Bourboulis EJ, Ifrim DC, Logie C, Jacobs L, Jansen T, Kullberg BJ, Wijmenga C, Joosten LA, Xavier RJ, van der Meer JW, Stunnenberg HG, and Netea MG. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 12: 223-232, 2012.
107. Rafehi H, Balcerczyk A, Lunke S, Kaspi A, Ziemann M, Kn H, Okabe J, Khurana I, Ooi J, Khan AW, Du XJ, Chang L, Haviv I, Keating ST, Karagiannis TC, and El-Osta A. Vascular histone deacetylation by pharmacological HDAC inhibition. Genome Res 24: 1271-1284, 2014.
108. Raghunathan S, Goyal RK, and Patel BM. Selective inhibition of HDAC2 by magnesium valproate attenuates cardiac hypertrophy. Can J Physiol Pharmacol 95: 260-267, 2017.
109. Raiber EA, Beraldi D, Ficz G, Burgess HE, Branco MR, Murat P, Oxley D, Booth MJ, Reik W, and Balasubramanian S. Genome-wide distribution of 5-formylcytosine in embryonic stem cells is associated with transcription and depends on thymine DNA glycosylase. Genome Biol 13: R69, 2012.
110. Ren W, Wang C, Wang Q, Zhao D, Zhao K, Sun D, Liu X, Han C, Hou J, Li X, Zhang Q, Cao X, and Li N. Bromodomain protein Brd3 promotes Ifnb1 transcription via enhancing IRF3/p300 complex formation and recruitment to Ifnb1 promoter in macrophages. Sci Rep 7: 39986, 2017.
111. Rizzetto L, Ifrim DC, Moretti S, Tocci N, Cheng SC, Quintin J, Renga G, Oikonomou V, De Filippo C, Weil T, Blok BA, Lenucci MS, Santos MA, Romani L, Netea MG, and Cavalieri D. Fungal chitin induces trained immunity in human monocytes during cross-talk of the host with Saccharomyces cerevisiae. J Biol Chem 291: 7961-7972, 2016.
112. Rodrigues J, Brayner FA, Alves LC, Dixit R, and Barillas-Mury C. Hemocyte differentiation mediates innate immune memory in Anopheles gambiae mosquitoes. Science 329: 1353-1355, 2010.
113. Rosenthal SR, Loewinsohn E, Graham ML, Liveright D, Thorne MG, and Johnson V. BCG vaccination in tuberculous households. Am Rev Respir Dis 84: 690-704, 1961.
114. Ruthenburg AJ, Allis CD, and Wysocka J. Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 25: 15-30, 2007.
115. Saeed S, Quintin J, Kerstens HH, Rao NA, Aghajanirefah A, Matarese F, Cheng SC, Ratter J, Berentsen K, van der Ent MA, Sharifi N, Janssen-Megens EM, Ter Huurne M, Mandoli A, van Schaik T, Ng A, Burden F, Downes K, Frontini M, Kumar V, Giamarellos-Bourboulis EJ, Ouwehand WH, van der Meer JW, Joosten LA, Wijmenga C, Martens JH, Xavier RJ, Logie C, Netea MG, and Stunnenberg HG. Epigenetic programming of monocyte-tomacrophage differentiation and trained innate immunity. Science 345: 1251086, 2014.
116. Sanchez R, Meslamani J, and Zhou MM. The bromodomain: from epigenome reader to druggable target. Biochim Biophys Acta 1839: 676-685, 2014.
117. Santos-Rosa H, Valls E, Kouzarides T, and Martinez-Balbas M. Mechanisms of P/CAF auto-acetylation. Nucleic Acids Res 31: 4285-4292, 2003.
118. Schoors S, De Bock K, Cantelmo AR, Georgiadou M, Ghesquiere B, Cauwenberghs S, Kuchnio A, Wong BW, Quaegebeur A, Goveia J, Bifari F, Wang X, Blanco R, Tembuyser B, Cornelissen I, Bouche A, Vinckier S, Diaz-Moralli S, Gerhardt H, Telang S, Cascante M, Chesney J, Dewerchin M, and Carmeliet P. Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis. Cell Metab 19: 37-48, 2014.
119. Shirai T, Nazarewicz RR, Wallis BB, Yanes RE, Watanabe R, Hilhorst M, Tian L, Harrison DG, Giacomini JC, Assimes TL, Goronzy JJ, and Weyand CM. The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease. J Exp Med 213: 337-354, 2016.
120. Sikalidis AK. Amino acids and immune response: a role for cysteine, glutamine, phenylalanine, tryptophan and arginine in T-cell function and cancer? Pathol Oncol Res 21: 9-17, 2015.
121. Skvortsova K, Zotenko E, Luu PL, Gould CM, Nair SS, Clark SJ, and Stirzaker C. Comprehensive evaluation of genome-wide 5-hydroxymethylcytosine profiling approaches in human DNA. Epigenetics Chromatin 10: 16, 2017.
122. Song CX, Szulwach KE, Dai Q, Fu Y, Mao SQ, Lin L, Street C, Li Y, Poidevin M, Wu H, Gao J, Liu P, Li L, Xu GL, Jin P, and He C. Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell 153: 678-691, 2013.
123. Sterner DE and Berger SL. Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 64: 435-459, 2000.
124. Stewart MD, Li J, and Wong J. Relationship between histone H3 lysine 9 methylation, transcription repression, and heterochromatin protein 1 recruitment. Mol Cell Biol 25: 2525-2538, 2005.
125. Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, Frezza C, Bernard NJ, Kelly B, Foley NH, Zheng L, Gardet A, Tong Z, Jany SS, Corr SC, Haneklaus M, Caffrey BE, Pierce K, Walmsley S, Beasley FC, Cummins E, Nizet V, Whyte M, Taylor CT, Lin H, Masters SL, Gottlieb E, Kelly VP, Clish C, Auron PE, Xavier RJ, and O'Neill LA. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature 496: 238-242, 2013.
126. Torre C, Abnave P, Tsoumtsa LL, Mottola G, Lepolard C, Trouplin V, Gimenez G, Desrousseaux J, Gempp S, Levasseur A, Padovani L, Lemichez E, and Ghigo E. Staphylococcus aureus promotes Smed-PGRP-2/Smedsetd8-1 methyltransferase signalling in planarian neoblasts to sensitize anti-bacterial gene responses during re-infection. EBioMedicine 20: 150-160, 2017.
127. Torres-Adorno AM, Lee J, Kogawa T, Ordentlich P, Tripathy D, Lim B, and Ueno NT. Histone deacetylase inhibitor enhances the efficacy of MEK inhibitor through NOXA-mediated MCL1 degradation in triple-negative and inflammatory breast cancer. Clin Cancer Res 23: 4780-4792, 2017.
128. Torres IO and Fujimori DG. Functional coupling between writers, erasers and readers of histone and DNA methylation. Curr Opin Struct Biol 35: 68-75, 2015.
129. Trunz BB, Fine P, and Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367: 1173-1180, 2006.
130. van 't Wout JW, Poell R, and van Furth R. The role of BCG/PPD-activated macrophages in resistance against systemic candidiasis in mice. Scand J Immunol 36: 713-719, 1992.
131. van Dam AD, Bekkering S, Crasborn M, van Beek L, van den Berg SM, Vrieling F, Joosten SA, van Harmelen V, de Winther MPJ, Lutjohann D, Lutgens E, Boon MR, Riksen NP, Rensen PCN, and Berbee JFP. BCG lowers plasma cholesterol levels and delays atherosclerotic lesion progression in mice. Atherosclerosis 251: 6-14, 2016.
132. Van den Bossche J, Baardman J, and de Winther MP. Metabolic characterization of polarized M1 and M2 bone marrow-derived macrophages using real-time extracellular flux analysis. J Vis Exp 28: 2015.
133. Van den Bossche J, O'Neill LA, and Menon D. Macrophage immunometabolism: where are we (going)? Trends Immunol 38: 395-406, 2017.
134. van der Valk FM, Bekkering S, Kroon J, Yeang C, Van den Bossche J, van Buul JD, Ravandi A, Nederveen AJ, Verberne HJ, Scipione C, Nieuwdorp M, Joosten LA, Netea MG, Koschinsky ML, Witztum JL, Tsimikas S, Riksen NP, and Stroes ES. Oxidized phospholipids on lipoprotein(a) elicit arterial wall inflammation and an inflammatory monocyte response in humans. Circulation 134: 611-624, 2016.
135. van Diepen JA, Thiem K, Stienstra R, Riksen NP, Tack CJ, and Netea MG. Diabetes propels the risk for cardiovascular disease: sweet monocytes becoming aggressive? Cell Mol Life Sci 73: 4675-4684, 2016.
136. Venkatesh S and Workman JL. Histone exchange, chromatin structure and the regulation of transcription. Nat Rev Mol Cell Biol 16: 178-189, 2015.
137. Vento-Tormo R, Alvarez-Errico D, Rodriguez-Ubreva J, and Ballestar E. Gains of DNA methylation in myeloid terminal differentiation are dispensable for gene silencing but influence the differentiated phenotype. FEBS J 282: 1815-1825, 2015.
138. Vento-Tormo R, Company C, Rodriguez-Ubreva J, de la Rica L, Urquiza JM, Javierre BM, Sabarinathan R, Luque A, Esteller M, Aran JM, Alvarez-Errico D, and Ballestar E. IL-4 orchestrates STAT6-mediated DNA demethylation leading to dendritic cell differentiation. Genome Biol 17: 4, 2016.
139. Waddington CH. The epigenotype. 1942. Int J Epidemiol 41: 10-13, 2012.
140. Wang X, Cao Q, Yu L, Shi H, Xue B, and Shi H. Epigenetic regulation of macrophage polarization and inflammation by DNA methylation in obesity. JCI Insight 1: e87748, 2016.
141. Warburg O, Wind F, and Negelein E. The metabolism of tumors in the body. J Gen Physiol 8: 519-530, 1927.
142. Wolk K, Docke W, von Baehr V, Volk H, and Sabat R. Comparison of monocyte functions after LPS-or IL-10-induced reorientation: importance in clinical immunoparalysis. Pathobiology 67: 253-256, 1999.
143. Xiao M, Yang H, Xu W, Ma S, Lin H, Zhu H, Liu L, Liu Y, Yang C, Xu Y, Zhao S, Ye D, Xiong Y, and Guan KL. Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev 26: 1326-1338, 2012.
144. Xie Z, Dai J, Dai L, Tan M, Cheng Z, Wu Y, Boeke JD, and Zhao Y. Lysine succinylation and lysine malonylation in histones. Mol Cell Proteomics 11: 100-107, 2012.
145. Xu Y, Zhang S, Lin S, Guo Y, Deng W, Zhang Y, and Xue Y. WERAM: a database of writers, erasers and readers of histone acetylation and methylation in eukaryotes. Nucleic Acids Res 45: D264-D270, 2017.
146. Yanez A, Hassanzadeh-Kiabi N, Ng MY, Megias J, Subramanian A, Liu GY, Underhill DM, Gil ML, and Goodridge HS. Detection of a TLR2 agonist by hematopoietic stem and progenitor cells impacts the function of themacrophages they produce. Eur J Immunol 43: 2114-2125, 2013.
147. Yang J, Huang J, Dasgupta M, Sears N, Miyagi M, Wang B, Chance MR, Chen X, Du Y, Wang Y, An L, Wang Q, Lu T, Zhang X, Wang Z, and Stark GR. Reversible methylation of promoter-bound STAT3 by histonemodifying enzymes. Proc Natl Acad Sci U S A 107: 21499-21504, 2010.
148. Yang XD, Huang B, Li M, Lamb A, Kelleher NL, and Chen LF. Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit. EMBO J 28: 1055-1066, 2009.
149. Yoshida K and Ishii S. Innate immune memory via ATF7-dependent epigenetic changes. Cell Cycle 15: 3-4, 2016.
150. Yoshida K, Maekawa T, Zhu Y, Renard-Guillet C, Chatton B, Inoue K, Uchiyama T, Ishibashi K, Yamada T, Ohno N, Shirahige K, Okada-Hatakeyama M, and Ishii S. The transcription factor ATF7 mediates lipopolysaccharideinduced epigenetic changes in macrophages involved in innate immunological memory. Nat Immunol 16: 1034-1043, 2015.
151. Yu J, Qiu Y, Yang J, Bian S, Chen G, Deng M, Kang H, and Huang L. DNMT1-PPARgamma pathway in macrophages regulates chronic inflammation and atherosclerosis development in mice. Sci Rep 6: 30053, 2016.
152. Zampetaki A, Zeng L, Margariti A, Xiao Q, Li H, Zhang Z, Pepe AE, Wang G, Habi O, deFalco E, Cockerill G, Mason JC, Hu Y, and Xu Q. Histone deacetylase 3 is critical in endothelial survival and atherosclerosis development in response to disturbed flow. Circulation 121: 132-142, 2010.
153. Zhang Z, Tan M, Xie Z, Dai L, Chen Y, and Zhao Y. Identification of lysine succinylation as a new posttranslational modification. Nat Chem Biol 7: 58-63, 2011.
154. Zimmer S, Grebe A, and Latz E. Danger signaling in atherosclerosis. Circ Res 116: 323-340, 2015.